Skip to content
ESSA Pharma
  • Our Company
    • About Us
    • Executive Team
    • Board of Directors
    • Scientific Advisors
    • Careers
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Androgen Receptor
    • Aniten Compounds
    • Publications
  • News
  • Investors
    • Investor Info
    • Corporate Governance
    • Events & Presentations
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Investor Contact
    • Publications
    • SEC Regulatory Filings
  • Contact
ESSA PHARMA, INC. HAS BEGUN DEVELOPMENT OF A SECOND GENERATION ANITEN COMPOUND FOR THE TREATMENT OF HORMONE-DRIVEN CANCER

News

News Archives

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
Date Title
December 15, 2015

ESSA PHARMA ANNOUNCES FILING OF PRELIMINARY SHELF PROSPECTUS AND REGISTRATION STATEMENT

December 14, 2015

ESSA PHARMA INC. REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2015

November 24, 2015

ESSA Announces Enrollment of First Patient in Phase 1/2 Trial

November 5, 2015

ESSA Pharma Inc. Receives Health Canada Approval to Commence Clinical Development for EPI-506

September 23, 2015

ESSA Pharma Inc. Receives FDA Approval to Commence Clinical Development

August 17, 2015

ESSA PHARMA INC. REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS

July 28, 2015

ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange

July 2, 2015

ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market

June 24, 2015

ESSA Pharma Inc. Announces Appointment of New Director

May 28, 2015

ESSA PHARMA INC. REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS

  • 1
  • 2
  • »
  • Home
  • Our Company
  • Executive Team
  • Board of Directors
  • Scientific Advisors
  • Careers
  • Pipeline
  • Expanded Access Policy
  • Androgen Receptor
  • Aniten Compounds
  • Publications
  • News
  • Press Releases
  • Investors
  • Corporate Governance
  • Events & Presentations
  • Financial Information
  • Stock Information
  • Analyst Coverage
  • Investor Contact
  • Contact
  • Locations & Inquiries
© ESSA Pharma, Inc. 2020. All rights reserved. Privacy Policy | Terms & Conditions | Code of Conduct